Product Information
GALANTAMINE HBR 12 MG TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.6640 per EA under NDC 70436000606. Its NADAC has been published 337 times since Jan 31, 2018.
FDA first approved this application on Feb 6, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436000606
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
GALANTAMINE HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077604FDA Approved
2/6/2009
TE Code
AB
On Market Since
8/2/2017
Pharmacological Classes
Price Statistics
The NADAC for GALANTAMINE HBR 12 MG TABLET has been published 337 times since Jan 31, 2018, and over the history we have for it it has declined 11.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6640 per EA |
|---|---|
| All-time high | $0.8319 (Nov 16, 2022) |
| All-time low | $0.2712 (Feb 21, 2024) |
| Median price | $0.6312 |
| Average price | $0.5920 |
| Largest weekly change | +126.6% (Jan 19, 2022) |
| Weeks tracked | 337 |
| Tracking since | Jan 31, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+29.3%
5Y
+80.9%
All
-11.9%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GALANTAMINE HBR 12 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GALANTAMINE HBR 12 MG TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.6640 per EA (NDC 70436000606), effective May 14, 2025.
How has the price of GALANTAMINE HBR 12 MG TABLET changed over time?
Over the history we have for it, the NADAC for GALANTAMINE HBR 12 MG TABLET has declined 11.9%. It has been tracked across 337 weekly CMS publications since Jan 31, 2018.
What are the highest and lowest recorded NADAC prices for GALANTAMINE HBR 12 MG TABLET?
Since Jan 31, 2018, the NADAC for GALANTAMINE HBR 12 MG TABLET has ranged from a low of $0.2712 (Feb 21, 2024) to a high of $0.8319 (Nov 16, 2022), with a median of $0.6312 per EA.
Are there cheaper alternatives to GALANTAMINE HBR 12 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GALANTAMINE HBR 12 MG TABLET, is $0.5332 per EA — about 20% below GALANTAMINE HBR 12 MG TABLET.
Who manufactures GALANTAMINE HBR 12 MG TABLET?
GALANTAMINE HBR 12 MG TABLET (NDC 70436000606) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.